Swedish Orphan Biovitrum AB (publ): insider trades · Finland · FIN-FSA FI:swedish-orphan-biovitrum-ab-publ SE0000872095 FI FI · FIN-FSA Mcap 150.8Bn€ Healthcare
Discover the full insider trade history of Swedish Orphan Biovitrum AB (publ), a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Swedish Orphan Biovitrum AB (publ) has logged 9 insider filings. Market capitalisation: €150.8bn. The latest transaction was filed on 17 May 2026 (Purchase). Among the most active insiders: Sofiane FAHMY. The full history is openly available.
€196,894
1 ops.
Sell Volume
Financial data FY ended December 2025 · cache
Analyst consensus
13 analysts 308.00 € Target 456.77 €(+5%) 530.00 €
Income statement
Revenue 28.24 Bn€
Gross profit 21.99 Bn€ 78% margin
Net income 478.0 M€ 3.2% margin
Valuation
PER (trailing) 167.0x
PER (forward) 19.3x
P/Book 3.7x
Beta 0.26
Balance sheet & cash
Market cap 150.78 Bn€
Total debt 11.49 Bn€
Free Cash Flow 5.41 Bn€
Debt / Equity 47%
Profitability & ownership
ROE 2.3%
ROA 7.0%
% insiders 10.1%
% institutions 73.3%
Last declaration on 17 May 2026
Declarations 9 total
Executives ● Purchase22 FIN-FSA
€1m 62,329 shares @ €19.1507 0.0008% mcap 100.0% of flow SE0000872095⌘
Aktie
FI:A003Y500-2 · 11 May 2026
Ideal exit: 5 Feb 2027 (T+270) Executives ● Purchase18 FIN-FSA
M
Mahmood Ladha Annan medlem i bolagets administrations-, lednings- eller kontrollorgan €1m 68,104 shares @ €19.092 0.0009% mcap 100.0% of flow SE0000872095⌘
Aktie
FI:A003T085-1 · 24 Oct 2025
Ideal exit: 21 Jul 2026 (T+270) Executives ● Purchase30 FIN-FSA
€1m 65,835 shares @ €19.092 0.0008% mcap 100.0% of flow SE0000872095⌘
Aktie
FI:A003T071-1 · 24 Oct 2025
Ideal exit: 21 Jul 2026 (T+270) Executives ● Purchase18 FIN-FSA
D
Duane Barnes Annan medlem i bolagets administrations-, lednings- eller kontrollorgan €66,745 3,588 shares @ €18.6023 0.0000% mcap 100.0% of flow SE0000872095⌘
Aktie
FI:A003R197-1 · 31 Jul 2025
Ideal exit: 27 Apr 2026 (T+270) Executives ● Purchase17 FIN-FSA
€558,584 30,343 shares @ €18.409 0.0004% mcap 73.9% of flow SE0000872095⌘
Aktie
FI:A003Q808-1 · 18 Jul 2025
Ideal exit: 14 Apr 2026 (T+270) Executives ● Sale13 FIN-FSA
€196,894 7,723 shares @ €25.4944 0.0001% mcap 26.1% of flow SE0000872095⌘
Aktie
FI:A003Q722-1 · 16 Jul 2025
Executives ● Purchase14 FIN-FSA
09,462 shares 0SE0000872095⌘
Aktie
FI:A003P675-1 · 10 Jun 2025
Ideal exit: 7 Mar 2026 (T+270) Executives ● Purchase14 FIN-FSA
015,862 shares 0SE0000872095⌘
Aktie
FI:A003P593-2 · 10 Jun 2025
Ideal exit: 7 Mar 2026 (T+270) Executives ● Purchase10 FIN-FSA
014,819 shares 0SE0000872095⌘
Aktie
FI:A003P581-1 · 10 Jun 2025
Ideal exit: 7 Mar 2026 (T+270)